Found 307 results for oasmia-pharmaceutical

Custom tombstone recognizing legal advisory work in two transactions involving pharmaceutical company Shionogi: an acquisition and a licensing agreement.

Density bottle-themed Lucite tombstone commemorating a Swiss Franc-denominated bond issue. Credit Suisse and Deutsche Bank served as joint active book runners for this debt issue by Swiss pharmaceutical firm Vifor Pharma.

Custom crystal commemorating a research collaboration involving Neurocrine Biosciences and Jnana Therapeutics. The research centers on finding new small-molecule therapeutics targeting central nervous system disorders.

Custom Lucite deal toy commemorating the acquisition of San Diego-based Ultimate Labs, a testing laboratory for the pharmaceutical, biotechnology, medical device, and food industries.

Custom Lucite, with an embedded champagne cork, celebrating the approval by the Food and Drug Administration (FDA) of the obesity treatment Plenity. Plenity was developed by Boston-based biotech firm Gelesis.

Custom crystal tombstone recognizing a follow-on offering by Jaguar Health, a commercial state pharmaceutical company.

Custom Lucite tombstone commemorating the acquisition of Quadrants Scientific, a San Diego-based chemical and microbiological testing laboratory.

Custom crystal commemorative, incorporating a periodic table theme, marking a licensing and commercialization agreement for a cancer drug developed by Rockville, Maryland-based biotech firm GlycoMimetics. The agreement applies to mainland China, Hong Kong, Taiwan, and Macau.

Crystal deal toy, featuring a 3D laser-etch of lungs, commemorating a drug commercialization agreement in Japan. The collaboaration between biotherapeutics firm aTyr Pharma and Kyorin Pharmaceutical centers on a treatment for lung diseases.